Inpatient Costs of Major Cardiovascular Events

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.3, 2001-03, pp. : 205-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Unit Costs of Inpatient Hospital Days

By Oostenbrink J.B.

PharmacoEconomics, Vol. 21, Iss. 4, 2003-01 ,pp. : 263-271

Adis International

Access to resources Recommend Favorite

Clopidogrel plus aspirin [acetylsalicylic acid] inhibits the early activation of platelets and reduces the prevalence of major adverse cardiovascular events

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ranolazine dose not reduce the risk of major cardiovascular events in patients with acute coronary syndromes

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?: A Synthesis of the Available Evidence

By Salpeter Shelley R.

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2025-2033

Adis International

Access to resources Recommend Favorite